trending Market Intelligence /marketintelligence/en/news-insights/trending/c5qk9d_p-fyeatsu6o3m6w2 content esgSubNav
In This List

Ampio Pharmaceuticals plans common stock, warrants offering

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Ampio Pharmaceuticals plans common stock, warrants offering

Englewood, Colo.-based Ampio Pharmaceuticals Inc. plans to sell its common shares and accompanying warrants to buy common shares in an underwritten public offering.

The clinical trial stage biopharmaceutical company will sell all of the securities in the proposed offering.

Net proceeds from the offering will be used for working capital and general corporate purposes, including continued preclinical development of Ampion and funding an Ampion clinical trial, if required.

Canaccord Genuity is acting as sole book-running manager for the proposed offering.